Cliff Asness's AMLX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 29,089 shares of Amylyx Pharmaceuticals, Inc. (AMLX) worth $404,338, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AMLX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 3.22 M shares. Largest reduction occurred in Q3 2024, reducing 2.69 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Amylyx Pharmaceuticals (AMLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amylyx Pharmaceuticals (AMLX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,242 | Add 4.46% | 29,089 | $13.90 |
| Q4 2025 | -45,793 | Reduce 62.18% | 27,847 | $12.08 |
| Q3 2025 | +73,640 | New Buy | 73,640 | $13.59 |
| Q1 2025 | -188,386 | Sold Out | 0 | $0.00 |
| Q4 2024 | -460,693 | Reduce 70.98% | 188,386 | $3.78 |
| Q3 2024 | -2.69 M | Reduce 80.57% | 649,079 | $3.24 |
| Q2 2024 | +3.22 M | Add 2768.03% | 3.34 M | $1.90 |
| Q1 2024 | +93,145 | Add 399.01% | 116,489 | $2.84 |
| Q4 2023 | -295 | Reduce 1.25% | 23,344 | $14.72 |
| Q3 2023 | +9,408 | Add 66.11% | 23,639 | $18.31 |
| Q2 2023 | +6,384 | Add 81.36% | 14,231 | $21.57 |
| Q1 2023 | +7,847 | New Buy | 7,847 | $29.34 |
Cliff Asness's Amylyx Pharmaceuticals Investment FAQs
Cliff Asness first purchased Amylyx Pharmaceuticals, Inc. (AMLX) in Q1 2023, acquiring 7,847 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Amylyx Pharmaceuticals, Inc. (AMLX) for 12 quarters since Q1 2023.
Cliff Asness's largest addition to Amylyx Pharmaceuticals, Inc. (AMLX) was in Q2 2024, adding 3,340,943 shares worth $6.35 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 29,089 shares of Amylyx Pharmaceuticals, Inc. (AMLX), valued at approximately $404,338.
As of the Q1 2026 filing, Amylyx Pharmaceuticals, Inc. (AMLX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Amylyx Pharmaceuticals, Inc. (AMLX) was 3,340,943 shares, as reported at the end of Q2 2024.